The U.S. government has contracted with companies like North Carolina-based GlaxoSmithKline, which is getting $2.8 million to produce 84,300 treatment courses of the antiviral drug Relenza (zanamivir).
Guess its a start
http://www.foxnews.com/story/0,2933,177884,00.html
- Forums
- ASX - By Stock
- BTA
- well, at least the us has made 1 order
well, at least the us has made 1 order
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)